Natasha Muench changed their profile picture 7 months, 2 weeks ago
-
Natasha Muench wrote a new post 7 months, 2 weeks ago
Positive Response to New Neoadjuvant Treatment Combination for Gastric and Gastroesophageal Cancer
Despite advances in treatment options, most patients diagnosed with non-metastatic((cancer that has not yet spread to other organs) gastric or […] -
Natasha Muench wrote a new post 10 months, 1 week ago
Celebrating a Lifetime of Achievement: Dr Eric Van Cutsem Honoured as Professor Emeritus
Dr Eric Van Cutsem, world-renowned Professor of Clinical Digestive Oncology and co-founder of Digestive Cancers Europe, was lauded as Professor […] -
Natasha Muench wrote a new post 1 year ago
Economist Impact: World Cancer Series Europe
On 20 September, the Belgian delegation of the DiCE Team attended the Economist Impact’s World Cancer Series: Europe in Brussels, proudly supporting […] -
Natasha Muench wrote a new post 1 year ago
Do You Dare to Think Differently about Cancer?
The Cancer Grand Challenges mission is “Uniting the World’s brightest minds against cancer’s toughest […] -
Natasha Muench wrote a new post 1 year, 2 months ago
ESMO Study Confirms Precision Oncology Remains Largely Inaccessible to European Cancer Patients
As a European umbrella organisation, DiCE is vocal in addressing the disparities associated with cancer patients’ access to precision medicine […] -
Natasha Muench wrote a new post 1 year, 2 months ago
Primary and Updated Analyses for DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer
Human Epidermal Growth receptor 2 (HER2) is a protein involved in normal cell growth, found in small amounts in almost all human cells, including […] -
Natasha Muench wrote a new post 1 year, 7 months ago
The devastating earthquakes that struck southern Turkey and northern Syria on 6 February have destroyed homes, […] -
Natasha Muench wrote a new post 1 year, 7 months ago
<strong>DiCE Supports Act4Biosimilars to Increase Patient Access to Biologic Medicines</strong>
Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater […] -
Natasha Muench wrote a new post 1 year, 7 months ago
<strong>16 February is World Cholangiocarcinoma Day</strong>
16 February is World Cholangiocarcinoma (CCA) Day. World CCA Day was previously held on 12 February. However, […] -
Natasha Muench wrote a new post 2 years, 6 months ago
The two most common types of oesophageal cancer are squamous cell carcinoma (OSCC) and adenocarcinoma (OAC). The majority of oesophageal cancers belong to the OSCC sub-type, accounting for more than 85% of all […]
-
